NCT06548633

Brief Summary

The aim of this study was to establish the efficacy of spinal mobilisations (a controlled application of a specific amount of force to a targeted spinal level) for reducing pain across different areas of the lower back. Pain was assessed using a pin prick sensation device and recorded in specific locations by the participant using a 10 cm line with one end indicating no pain and the other the worst pain possible.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2019

Completed
5.2 years until next milestone

First Submitted

Initial submission to the registry

August 2, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 12, 2024

Completed
Last Updated

August 12, 2024

Status Verified

August 1, 2024

Enrollment Period

4 months

First QC Date

August 2, 2024

Last Update Submit

August 7, 2024

Conditions

Keywords

Vertebral Lumbar MobilisationsHypoalgesiaPinprick sensitivity (PPS)Neuropen®

Outcome Measures

Primary Outcomes (1)

  • Pinprick sensitivity (PPS)

    Using a Neuropen® (Owen Mumford, Oxfordshire, UK) a standardised force of 40g was applied to one of the dermatome locations. The participant then received a small piece of card with a vertical 10cm visual analogue scale (VAS) line on it and a pen and was asked to "draw a horizontal line on the scale to indicate how much sensation you feel, 0 being can-not feel anything and 10 being an extremely strong sensation". Following this explanation, the participant was asked if they understood and whether they needed further instruction to complete the VAS card. Once the participant marked the card, the card and pen were collected and stored, this process was repeated with the remaining four locations (these five cards provided the baseline data). A new tip was used for each participant, and a decrease in PPS represents a reduction in pain.

    Up to 15 minutes

Study Arms (1)

Vertebral Lumbar Mobilisations

EXPERIMENTAL

Participants received the intervention.

Other: Lumbar Vertebral Mobilisation

Interventions

The participants received Vertebral Lumbar Mobilisations, these were posterior-anterior central vertebral pressures (PACVPs) for four sets of 30 seconds, with up to 30s between each, at a grade III amplitude.

Vertebral Lumbar Mobilisations

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy and consent.

You may not qualify if:

  • Yes to any Vertebral Mobilisation Contraindication.
  • Consulted a doctor within the last 6 months?
  • Presently taking any form of medication?
  • Suffered from a bacterial or viral infection in the last 2 weeks?
  • Ever suffered from any form of heart complaint?
  • Family history of heart disease?
  • Ever suffered from: Asthma, Diabetes, Bronchitis, Epilepsy, High blood pressure or Low blood pressure?
  • Currently have any form of muscle or joint injury?
  • Had to suspend training in the last two weeks for a physical reason?
  • Is there anything that may prevent the successful completion of the tests that have been outlined?
  • Any "yes" answers to any of the questions above will require further detail, then the answers will be assessed to establish the potential risks to the participant and established if it is safe to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Worcester

Worcester, Worcestershire, WR5 3WP, United Kingdom

Location

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Darren Cooper, Dr

    University of Worcester

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
The participants were blinded to the intervention they were receiving.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: The design of the study was a randomised, single-blind, repeated measures, cross-over design, performed in a single-centre environment.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Lecturer in Sports Therapy

Study Record Dates

First Submitted

August 2, 2024

First Posted

August 12, 2024

Study Start

October 4, 2018

Primary Completion

February 1, 2019

Study Completion

May 28, 2019

Last Updated

August 12, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

IPD used in the results publication will be available upon request.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
December 2024 onwards
Access Criteria
Emailing the study contact.
More information

Locations